First, as a result of the rarity of PALB2-associated breast cancers, the small sample size may have limited the detection of significant differences in the exploratory analyses comparing PALB2-associated breast cancers with non-BRCA1/2/PALB2-associated breast cancers from TCGA. Here, PALB2 is linked to breast carcinoma.